Document 2277 DOCN M94A2277 TI Psychiatric follow-up of volunteers in an HIV vaccine trial. DT 9412 AU Linard F; Stoessel P; Giami A; Souteyrand Y; INSERM U. 158, France. SO Int Conf AIDS. 1994 Aug 7-12;10(1):340 (abstract no. PC0294). Unique Identifier : AIDSLINE ICA10/94370298 AB OBJECTIVES: 1. To assess the psychological risks for volunteer participation in an HIV Vaccine trial, through a psychiatric evaluation; 2. To estimate the quality of the volunteers' commitment throughout the trial and to limit the risk of dropping out of the protocol; 3. To watch over the ethical aspects of the whole process particular with respect to the integrity of individuals considered as human subjects. METHOD: 1. Dimensions of psychiatrists' participation in the selection process: A. Conception--with the other members of the staff--of the ANRS call for volunteers through the press; B. Examination and selection of volunteers' motivation letters; C. Double Consultation (internist and psychiatrist) of the preselected volunteers; D. Participation in the final decision to include--or not--candidates in the volunteers' network. 2. Setting up the possibility of a psychological follow-up during the trials (upon volunteer's request) and Psychological interview after one year. RESULTS AND DISCUSSION: 1. Out of the 435 completed and returned files by the volunteers, 177 individuals were preselected for a psychiatric consultation; 60 were included in the volunteers' network and 45 participated in the VAC 001 and VAC 002 trials in 1992-93. The individuals not included in the network were: individuals presenting a risk linked to a previous history of psychotic disorder, inappropriate motivation or lack of commitment to the trial 2. No psycho pathological incidents nor any dropping out of the protocol were observed. 3. 44/45 volunteers accepted the final interview and expressed a positive attitude towards the trial. Therefore, some volunteers expressed emotional, imaginary and psycho-social repercussions linked to being HIV positive without the virus as a result of having been vaccinated. DE AIDS Vaccines/*ADMINISTRATION & DOSAGE Clinical Trials/*PSYCHOLOGY *Ethics, Medical Feasibility Studies Human HIV Infections/*PREVENTION & CONTROL/PSYCHOLOGY/TRANSMISSION HIV Seropositivity/PSYCHOLOGY/TRANSMISSION Motivation *Patient Acceptance of Health Care Patient Care Team Patient Dropouts/*PSYCHOLOGY Personality Assessment Risk Factors MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).